Archive for the ‘Testing’ Category

Fibromyalgia Associated With Borrelia-Specific T Lymphocytes

https://www.eurekaselect.com/article/129522

Antinuclear antibody seropositivity in fibromyalgia associated with Borrelia-specific T lymphocytes

Author(s): Basant K. Puri*Gary S. Lee and Armin Schwarzbach

DOI: 10.2174/1573397119666230215124048

Current Rheumatology Reviews 2023; 19()

Abstract

Background: Our group have recently reported that there is no evidence of an association between fibromyalgia and Borrelia-specific T lymphocytes. However, a small number of case reports has suggested that infection by the bacterial genus Borrelia may be associated with the presence of antinuclear antibodies (ANAs).

Objective: To test the hypothesis that those fibromyalgia patients who are ANA seropositive are more likely to show evidence of Borrelia-specific T lymphocyte reactivity than those who are seronegative.

Methods: T lymphocyte reactivity to Borrelia burgdorferi sensu stricto (full antigen) was assessed using the enzyme-linked immunospot and serum ANA status was assessed using immunofluorescence in 27 fibromyalgia patients fulfilling the revised diagnostic criteria of the American College of Rheumatology.

Results: The ANA seropositive and seronegative groups were matched for age, sex and ethnicity; the T lymphocyte reactivity to Borrelia burgdorferi sensu stricto (full antigen) in the former group (mean 5.60) was significantly higher than that in the seronegative group (mean 1.81; p < 0.05).

Conclusion: This novel study points to an association of ANA seropositivity in fibromyalgia with Borrelia-specific T lymphocytes.

For more:

More on U.S. Funding of Biolabs in Ukraine: A ‘Jobs Program’ for Foreign Scientists

If you wondered why mainstream and social media did a virtual blitzkrieg on immediately supporting Ukraine, which on an international corruption scale ranks just below China and Cuba, wonder no further. Now the Council of Europe’s Venice Commission will investigate Ukraine for violating and persecuting ethnic groups.

The media is a virtual puppet now being used by the government to influence and distract the public and to funnel billions into Ukraine.  You are also unlikely to hear from MSM that hundreds of children are listed (with all of their personal information) on a Kiev-backed kill list.  The UN has done nothing about it.

The DOD has budgeted $1.3 BILLION over the next five years to “supercharge” US soldiers’ immune systems to supposedly make them impervious to chemical and biological threats, requiring a close collaboration between the government and Big Pharma, but typically government “cures” drive out real cures.

For nearly a decade NIH, DARPA, and BARDA (hence millions of our tax dollars) have funded an implantable biochip using 5G that can detect viral respiratory diseases and control biological processes remotely, which opens the door to the potential manipulation of our biological responses.  Bill Gates enters the picture with a 2019 MIT study, funded by the Gates Foundation, which describes how “near-infrared quantum dots” can be implanted under the skin along with a vaccine to encode information for “decentralized data storage and bio-sensing.”  The entire project was motivated by Gates’ desire to identify those who have not been vaccinated, which is one step closer to happening as new, specific ICD codes have been created for those foregoing the ineffective, dangerous COVID clot shots that have caused more reports of adverse reactions and death than any other vaccine in the history of VAERS.

Here’s the frightening bit:

….developing individual preventative measures or cures for each known chemical or biological threat is no longer realistic, according to the document. Instead, DOD’s Chemical and Biological Defense Program (CBDP) will focus on finding ways to engineer servicemembers’ immune systems with catch-all vaccines, therapeutics and equipment that can handle a seemingly endless landscape of chemical and biological threats, including ones that aren’t directly the result of weapons programs, Politico first reported.

“There is also an expansion of high containment labs worldwide with ready access to powerful new technologies, increasing the risk of accidental and deliberate outbreaks, even pandemics,” he added.

CBDP will “leverage” existing relationships with pharmaceutical companies to fast-track development of immunization technologies, each of which can protect troops against multiple viruses, the Pentagon strategy states.

It appears the military/medical complex has completely given up on treatments.  All effort and money is being directed to a supposed magic bullet “vaccine” or experimental therapeutic “cure all.”  This is why repurposed drugs like HCQ with zinc, ivermectin, etc. are maligned, censored, banned, with legal battles and doctors being persecuted.

The CBDP is looking to “modulate the immune system” of soldiers through six different metabolic pathways as well as looking into monoclonal antibodies for three distinct groups of viruses including COVID, i.e. addressing many bugs with one drug.

  • Dr. Ruby discusses that in her experience those getting COVID again (which again, can’t be verified due to the PCR fraud occurring and the inability to know if something truly is COVID) have had experimental monoclonal antibodies or the jab.  Getting the antibodies is like renting an army for a day. They come in, clean house, but then go away.  On the other-hand, the soldiers in your immune system stay around, continuing to clean house as needed.  Those getting the jab are catching every little cold bug or flu that’s going around.

This will all be done by mimicking Operation Warp Speed‘s funding and fast-tracked regulations to make it all happen at the speed of light, like they did with the experimental COVID gene therapy shots, developed by the military which are strategically called “counter measures” and “prototypes,” to avoid lengthy conventional regulatory, commercial development and testing pathways normally required for pharmaceutical products (ICH, 2022) and to proceed to Emergency Use Authorization (EUA).

Of course they are also requesting a “unique medical infrastructure” designed to fast-track new “vaccines” and drugs as well as wearable devices that monitor vital signs.

These questions are begging to be asked:

  • Is THIS why the government insisted on the country-wide rollout of the COVID shots?
  • Is THIS why the government mandated that their own soldiers get them?
  • Are they already collecting information to feed this new experiment?

The following information on U.S. taxpayer funded bio labs in Ukraine will be déjà vu for those familiar with the sordid history of Lyme/MSIDS, which actually has a Wisconsin chapter.  A secret directive in 1946 by President Truman, originally coined “operation overcast,” fast-tracked immigration papers for more than a thousand former Nazi scientists. It was later renamed “Operation Paperclip” because a paper clip would be attached to someone’s file, indicating they were to be allowed in without scrutiny. These scientists formed the core that developed America’s nuclear missile program as well as weapons for America that almost certainly violated international law.  What doesn’t get a lot of air-play is the secret history of Lyme disease.

Creating a ‘jobs program’ for foreign scientists on the taxpayer’s dime isn’t new.

https://rumble.com/v1ysaqg-new-defense-department-records-reveal-u.s.-funding-of-anthrax-biolabs-in-uk.html  Video Here (Approx. 8 Min)

DOD Records Reveal U.S. Funding of Anthrax BioLabs in Ukraine

https://www.judicialwatch.org/documents/ukraine-biolabs-november-2022/  Documents Here

Judicial Watch obtained 345 pages of heavily redacted records under the umbrella of the DOD on the U.S. funding of anthrax lab activities in the Ukraine.  Russia requested the UN Security Council to investigate these bioweapons but was rejected.

“This is really a jobs program for Soviet scientists.

What do you do with all these labs and all these scientists hanging around who have very deadly toxins on their hands?  Well, you Co-op them.  Right?  So you create a program, you fund them, you let them do their experiments, but the idea since you are funding them, you’re controlling them. That’s the idea. Except that then it becomes inconvenient and awkward when things like wars pop up or when the Russians knock out all the electricity in Ukraine, and guess what’s needed to maintain those laboratories and the security of those pathogens in those labs?  Electricity. ~  Chris Farrell Director of Investigations and Research, Judicial Watch

In other words, experimenting with deadly pathogens has significant risk.

Yet, the laboratory work isolating deadly pathogens continues with a partnership with an investment firm directed by Hunter Biden and Christopher Heinz (stepson of climate czar John Kerry).

https://rumble.com/v28hf3e-dr.-andrew-huff-on-the-connection-between-hunter-biden-and-biolabs-in-ukrai.html  Video Here (Approx. 3 Min)

Dr. Andrew Huff on the Connection Between Hunter Biden & Biolabs in Ukraine

“Metabiota is the company that had the contracts w/ DTRA for the labs in Ukraine.

Metabiota is the company that was invested into by Rosemont Seneca, which was Hunter Biden’s VC firm.”

_____________

**Comment**

Circling back to Lyme for a moment, according to patent no. WO/2008/147879 filed with the World Intellectual Property Organization (WIPO), UMDNJ Biomedical Informatics expert Ryan Golhar PhD describes “a processing technique, associated method, product description, and related software… for achieving rapid identification of DNA”. The author explains how this can detect a very wide range of biological warfare pathogens:

“The present invention provides methods and devices for the identification of bioagents via the presence of their nucleic acids. In the context of the present invention, a ‘bioagent’ is any organism, living or dead, or a nucleic acid derived from such an organism. Examples of bioagents include but are not limited to cells (including but not limited to human clinical samples, bacterial cells and other pathogens) viruses, toxin genes and bioregulating compounds). Samples may be alive or dead or in a vegetative state (for example, vegetative bacteria or spores) and may be encapsulated or bioengineered.”  Source

Golhar then goes on to list the many biowarfare pathogens, which may be detected using his technique. The list is subdivided into bacterial, viral, toxin, and fungal weapons.

Bacterial biological warfare bioagents capable of being detected by the present methods include, but are not limited to:

  • Bacillus anthracis (anthrax)
  • Yersinia pestis (pneumonic plague)
  • Franciscella tularensis (tularemia)
  • Brucella suis
  • Brucella abortus
  • Brucella melitensis (undulant fever)
  • Burkholderia mallei (glanders)
  • Burkholderia pseudomalleii (melioidosis)
  • Salmonella typhi (typhoid fever)
  • Rickettsia typhii (epidemic typhus)
  • Rickettsia prowasekii (endemic typhus)
  • Coxiella burnetii (Q fever)
  • Rhodobacter capsulatus
  • Chlamydia pneumoniae
  • Escherichia coli
  • Shigella dysenteriae
  • Shigella flexneri
  • Bacillus cereus
  • Clostridium botulinum
  • Coxiella burnetti
  • Pseudomonas aeruginosa
  • Legionella pneumophila
  • Borrelia burgdorferi (LYME DISEASE)
  • Vibrio cholerae

The following excerpt says it all:

A hard-to-catch, easily cured disease that neither kills nor disables would hardly seem much of a choice as a bioweapon. Why then, do we hear, again and again, that the agent of Lyme is being studied in maximum-containment biowarfare labs?

When I exposed, a few years ago, a document I found on the US National Institute of Health’s website which listed Lyme as one of the pathogens studied in Fort Detrick, (the premier biowarfare lab in the US), the NIH quickly announced it was a “printing error” and removed the words Lyme disease from the page.

However, further leaks have resulted in similar information being accidentally released again and again. For example, Lyme was listed as one of the biowar agents to be studied in the new high-containment lab in San Antonio, Texas, in a report that was picked up by the Associated Press (3). After being publicized over the internet by Lyme disease patient campaigners, the link to the article was summarily removed by MSNBC; however, various archived copies survive.

A document on the website of Colorado State University revealed that Lyme was being studied in a top-security BSL-3 lab there. (4) Biosafety Level 3 is used for some of the most dangerous pathogens known, which additionally pose a major biowarfare hazard because of transmission by the airborne route. It is only one step down from BSL-4, the highest level of containment, reserved for those agents for which there is no known vaccine or treatment.

Lyme disease in nature is usually acquired by tick-bite and is not considered transmissible by the airborne route. But weaponisation usually involves creating fine-milled, aerosolisable particles – and techniques for lyophilisation, or freeze-drying of borrelia in fine particles – were developed decades ago. Source

It does appear that history repeats itself.

For more:

Patient Contracts Babesia From a Blood Donor: Only 14 States Test For It

https://danielcameronmd.com/patient-contracts-babesia-blood-donor/

PATIENT CONTRACTS BABESIA FROM A BLOOD DONOR

babesia-blood-donor

Babesia is most commonly transmitted through a tick bite but it can also be transmitted through a blood transfusion. To minimize the risk to the public, blood banks now screen donors for Babesia in endemic states.

In their article “Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange,” Costa and colleagues describe a patient who contracted Babesia from a donor living in Ohio, a state that is not considered endemic for Babesia

According to the authors, a 30-year-old man with sickle cell disease (SCD) required approximately 10 units of red blood cells every 3–4 weeks throughout his childhood.

Approximately 2 months after a red blood cell exchange, he presented with fever, neck pain, and photophobia. Several days later, he developed a persistent fever, chills, headache, fatigue, and loss of appetite.

He was diagnosed with Babesia through identification of parasites in his red blood cells and positive antibodies. He was also borderline positive on an antibody test for Anaplasma phagocytophilum and Ehrlichia chaffeensis.

“Prior to laboratory-based blood donor screening for Babesia, transfusion-transmitted babesiosis (TTB) was a leading infectious risk to the blood supply in the United States.”

The young man was treated for Babesia with azithromycin and atovaquone for 10 days with resolution of his symptoms. He was not treated for Anaplasma phagocytophilum or Ehrlichia chaffeensis.

The patient lived in a state endemic for Babesia but did not recall a tick bite.

“A donor lookback investigation was initiated with the blood supplier,” the authors wrote. They found that in the preceding 6 months, the patient had received 65 units of blood, with 58 units screened for Babesia.

Unfortunately, “One of the donors of the 7 untested units was B. microti seropositive,” the authors wrote. The donor lived in a state not requiring Babesia screening.

“Our case demonstrates the continued vulnerability of the US blood supply to Babesia.”

“The seropositive donor had not had any symptoms of babesiosis; he lived in Ohio and reported being very active over the past year, including hiking and camping in several states (Ohio, Tennessee, and North Carolina),” the authors wrote.

In 2019, the FDA recommended testing of blood donors for Babesia in the 14 states where almost all cases of Babesia have been reported. “The policy confined to 14 states (Connecticut, Delaware, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont, Virginia, Wisconsin),” wrote the authors.

Authors Conclude:

“Heightened awareness and health care provider education are imperative, especially in non-endemic [states] where clinicians may not be accustomed to diagnosing community-acquired or TTB, placing transfusion recipients at risk of delayed diagnosis and severe disease.

References:
  1. Costa V, Mercure-Corriveau N, Gourneau J, et al. Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange. Transfusion. Jan 13 2023;doi:10.1111/trf.17244

________________

**Comment**

Once again, the madness of limiting potential infection to certain geographical areas despite the ability of people, animals, and bugs to move around is completely asinine.  Yet, here we are – still in the madness.

For more:

Lyme Misinformation Has Physicians Searching For Guidance

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u

Lyme disease misinformation has physicians searching for guidance

Carl Tuttle

Hudson, NH, United States

JAN 20, 2023 — 

It appears that the CDC has partnered with Mathematica to start working on the “disinformation campaign” for the upcoming Lyme vaccine brought to you by Pfizer who paid the the largest health care fraud settlement in history for fraudulent marketing. $2.3 Billion!

Why not start an email campaign and tell these folks how Lyme disease has impacted your life?

Email addresses:

Arnold Chen achen@mathematica-mpr.com
Frederick Chen frederick.chen@ama-assn.org
Grace Marx gmarx@cdc.gov
Sara Berg sara.berg@ama-assn.org

Email to Arnold Chen, Senior Researcher at Mathematica…

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “achen@mathematica-mpr.com” <achen@mathematica-mpr.com>, “info@mathematica-mpr.com” <info@mathematica-mpr.com>
Cc: “grace.marx@cuanschutz.edu” <grace.marx@cuanschutz.edu>, “lwx1@cdc.gov” <lwx1@cdc.gov>, “frederick.chen@ama-assn.org” <frederick.chen@ama-assn.org>
Date: 01/19/2023 5:53 PM
Subject: Lyme disease misinformation has physicians searching for guidance

JAN 12, 2023

Lyme disease misinformation has physicians searching for guidance
https://www.ama-assn.org/delivering-care/public-health/lyme-disease-misinformation-has-physicians-searching-guidance

“False and misleading information about the diagnosis and treatment of Lyme disease is spreading and creating confusion for both physicians and patients,” Dr. Chen added. The report conducted with the CDC and Mathematica Policy Research is just the start and “will highlight some of the disinformation that patients with persistent, medically unexplained symptoms attributed to Lyme disease have been exposed to and how some physicians respond to that,” he said.

Mathematica
Princeton, NJ
Attn: Arnold Chen, Senior Researcher

Dear Dr. Chen,

Could you please answer the following questions:

1. Will the CDC and Mathematica report include the following reference:

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
____________________________________________

2. Will your report include the following references of seronegative Lyme disease:

Seronegativity in Lyme borreliosis and Other Spirochetal Infections (16 September 2003)
https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

3. Will the CDC and Mathematica report include the following:

Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 References)
https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

4. Were you aware that the Western blot reporting criteria was manipulated in 1995 to facilitate vaccine development? (Dearborn Conference)

That manipulation led to a reduction in diagnostic success rate to 31% as reported by Dr. Paul Fawcett during the 1995 Rheumatology Symposia:
 
1995 Rheumatology Symposia Abstract# 1254 Dr. Paul Fawcett et al.

See abstract here

Faulty misleading FDA approved antibody tests cannot be used to gauge treatment failure or success and are absolutely essential for hiding an antibiotic resistant/tolerant superbug.

What we have been dealing with here Dr. Chen (based on all the suppressed evidence I have shared with you) is deliberate mismanagement of a disease. A chronic relapsing seronegative disease does not fit the vaccine model and that is the root of the disinformation perpetuated by the CDC for three decades. Now you have been informed. What will you do with this information?

A response to this inquiry is requested.

Carl Tuttle
Independent Researcher
Hudson, NH

It is difficult to get a man to understand something when his salary depends upon his not understanding it” -Upton Sinclair, American novelist and social reformer

Cc:

-Frederick Chen, MD, chief health and science officer at the AMA

-Grace Marx, MD, MPH, medical epidemiologist with the Bacterial Diseases Branch at CDC’s Division of Vector-Borne diseases

________________

For more:

How the Industrial Medical Complex Promotes Disinformation to Perpetuate an Existing Dogma

Lyme/MSIDS has been in a never-ending time warp. For patients who are educated on the horrific backstory, they were completely aware of COVID madness before most of the public.  The same tricks have been used.  The same fraud, corruption, and lies Lymeland has been dealing with for over 40 years are now finally being seen and felt by the general pubic.

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf

(84%) had no findings of active Lyme disease??

Carl Tuttle

Hudson, NH, United States

JAN 17, 2023 — 

Here is how the industrial medical complex promotes the disinformation to perpetuate an existing dogma. You won’t find any of my references in Dr. Auwaerter’s publication.  Why is that???

Inquiry to Dr. Paul G. Auwaerter

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “pauwaert@jhmi.edu” <pauwaert@jhmi.edu>
Cc: “Takaaki-kobayashi@uiowa.edu” <Takaaki-kobayashi@uiowa.edu>, “yhiggins@jhmi.edu” <yhiggins@jhmi.edu>, “mmelia4@jhmi.edu” <mmelia4@jhmi.edu>, “mwoolley@researchamerica.org” <mwoolley@researchamerica.org>, “jalpert@shc.arizona.edu” <jalpert@shc.arizona.edu>
Date: 01/16/2023 2:57 PM
Subject: Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease
 
The American Journal of Medicine April 2022

Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease (Apr 2022)
https://www.sciencedirect.com/science/article/pii/S0002934321007920
Takaaki Kobayashi MD,  Yvonne Higgins MAS, MS  Michael T.Melia MD  Paul G.Auwaerter MD

Results

“Of 1261 referred patients, 1061 (84%) had no findings of active Lyme disease…”

Paul G. Auwaerter MD
Division of Infectious Diseases
Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, Md

Dear Dr. Auwaerter,

I read your abstract with great interest but I must ask the question; how did you determine that 84% had no findings of active Lyme disease? Were these results obtained through serology?

Seronegative Lyme disease has been reported for years. I have attached a list of publications for your review:

Seronegativity in Lyme borreliosis and Other Spirochetal Infections
(16 September 2003)
https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

For example:

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
____________________________________________

Patients who were featured in the 5min extended trailer for the documentary “Under our Skin” claim the following:

– Misdiagnosed with Chronic Fatigue Syndrome, Lupus, MS, Fibromyalgia, ALS

“Under our Skin” extended trailer (5min)
https://www.youtube.com/watch?v=sxWgS0XLVqw

____________________________________________

Western blot reporting criteria was manipulated in 1995 to facilitate vaccine development. (Dearborn Conference)

That manipulation led to a reduction in diagnostic success rate to 31% as reported by Dr. Paul Fawcett during the 1995 Rheumatology Symposia:

1995 Rheumatology Symposia Abstract# 1254 Dr. Paul Fawcett et al.

View Dr. Paul fawcett’s Abstract 1254 here

Dr. Fawcett has been the head of the research and clinical immunology laboratories since 1986. In addition, he serves as Chair of the IACUC and is a member of the IRB.

Source: https://www.nemoursresearch.org/snap/node/11969

Even more significant is Dennis Parenti’s 1998 vaccine presentation (Lyme.org at 1 hr 9 minutes). Dr. Parenti, medical director of the vaccine trial – the largest Lyme trial in history, discusses the research findings of seronegative Lyme. At 36% it is a common presentation. This proves that a negative western blot is meaningless. Since their patients were culture positive and/or DNA positive for Borrelia infection and western blot negative.
View Dennis Parenti’s 1998 vaccine presentation slide here

As you should know Dr. Auwaerter, serology cannot be used to gauge treatment failure or success so I ask the question again: how did you determine that 84% had no findings of active Lyme disease?

A response to this inquiry is requested.

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Joseph Alpert, MD, MACP Editor-in-Chief, The American Journal of Medicine

Mary Woolley President and CEO of Research!America